Free Trial

Great Lakes Advisors LLC Acquires New Holdings in Henry Schein, Inc. $HSIC

Henry Schein logo with Medical background

Key Points

  • Great Lakes Advisors LLC acquired 65,363 shares of Henry Schein, Inc. for approximately $4.48 million, representing a 0.05% stake in the company as reported in a recent SEC filing.
  • Henry Schein's stock had a price-to-earnings ratio of 21.82 and a market capitalization of $8.20 billion, with a recent trading range between $60.56 and $82.49 over the past year.
  • Analysts have mixed ratings for Henry Schein with a consensus price target of $76.67, where five analysts recommend a Buy and seven a Hold rating.
  • Five stocks we like better than Henry Schein.

Great Lakes Advisors LLC bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 65,363 shares of the company's stock, valued at approximately $4,477,000. Great Lakes Advisors LLC owned approximately 0.05% of Henry Schein as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Investment Management Corp VA ADV acquired a new position in shares of Henry Schein during the 4th quarter worth approximately $32,000. Rakuten Securities Inc. acquired a new position in shares of Henry Schein during the 1st quarter worth approximately $34,000. Whittier Trust Co. grew its position in shares of Henry Schein by 714.3% during the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after purchasing an additional 700 shares in the last quarter. Quarry LP acquired a new position in shares of Henry Schein during the 1st quarter worth approximately $71,000. Finally, UMB Bank n.a. grew its position in shares of Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Analyst Ratings Changes

HSIC has been the topic of a number of analyst reports. JPMorgan Chase & Co. decreased their target price on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Robert W. Baird reiterated a "neutral" rating and set a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Evercore ISI upgraded shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target on the stock in a research report on Tuesday, August 26th. Stifel Nicolaus reiterated a "hold" rating and set a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Finally, Leerink Partners set a $75.00 price target on shares of Henry Schein in a research report on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $76.67.

Check Out Our Latest Report on Henry Schein

Henry Schein Price Performance

NASDAQ:HSIC traded down $0.37 on Monday, hitting $68.64. The company had a trading volume of 281,501 shares, compared to its average volume of 1,735,293. The stock has a market capitalization of $8.32 billion, a price-to-earnings ratio of 22.10, a PEG ratio of 2.28 and a beta of 0.86. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The firm has a 50 day moving average of $69.32 and a two-hundred day moving average of $69.44. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein's revenue for the quarter was up 3.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.